Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zepp Health (ZEPP) Accumulated Expenses: 2016-2024

  • Zepp Health's Accumulated Expenses fell 15.46% to $37.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was $37.6 million, marking a year-over-year decrease of 15.46%. This contributed to the annual value of $37.6 million for FY2024, which is 15.46% down from last year.
  • According to the latest figures from Q4 2024, Zepp Health's Accumulated Expenses is $37.6 million, which was down 15.46% from $44.5 million recorded in Q4 2023.
  • Zepp Health's Accumulated Expenses' 5-year high stood at $49.6 million during Q4 2021, with a 5-year trough of $2.6 million in Q4 2022.
  • Its 3-year average for Accumulated Expenses is $28.2 million, with a median of $37.6 million in 2024.
  • In the last 5 years, Zepp Health's Accumulated Expenses tumbled by 94.81% in 2022 and then soared by 1,627.56% in 2023.
  • Quarterly analysis of 5 years shows Zepp Health's Accumulated Expenses stood at $38.7 million in 2020, then grew by 28.29% to $49.6 million in 2021, then slumped by 94.81% to $2.6 million in 2022, then spiked by 1,627.56% to $44.5 million in 2023, then fell by 15.46% to $37.6 million in 2024.
  • Its Accumulated Expenses stands at $37.6 million for Q4 2024, versus $44.5 million for Q4 2023 and $2.6 million for Q4 2022.